Lineage Cell Therapeutics
LCTX
#8221
Rank
NZ$0.26 B
Marketcap
$1.40
Share price
1.22%
Change (1 day)
-34.18%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$0.16 B

According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are NZ$0.16 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$0.15 B-17.99%
2022-12-31NZ$0.19 B-23.78%
2021-12-31NZ$0.25 B70.81%
2020-12-31NZ$0.14 B-19.7%
2019-12-31NZ$0.18 B22.93%
2018-12-31NZ$0.15 B-37.87%
2017-12-31NZ$0.24 B18.51%
2016-12-31NZ$0.20 B48.82%
2015-12-31NZ$0.13 B44.68%
2014-12-31NZ$95.59 M36.08%
2013-12-31NZ$70.25 M94.27%
2012-12-31NZ$36.16 M-38.42%
2011-12-31NZ$58.72 M-14.96%
2010-12-31NZ$69.05 M273.36%
2009-12-31NZ$18.49 M936.52%
2008-12-31NZ$1.78 M680.55%
2007-12-31NZ$0.22 M-75.24%
2006-12-31NZ$0.92 M-67.78%
2005-12-31NZ$2.86 M34.39%
2004-12-31NZ$2.13 M29.36%
2003-12-31NZ$1.64 M-42.34%
2002-12-31NZ$2.85 M-38.85%
2001-12-31NZ$4.67 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$0.53 B 219.94%๐Ÿ‡บ๐Ÿ‡ธ USA